Park Hotels Is Back in the Black. That's Not the Story.

# Park Hotels Is Back in the Black. That's Not the Story.

Let's start with what actually happened, because it's a real one. On August 6th, Park Hotels & Resorts walked into the Q2 2026 print expecting a beat-and-rename and delivered both: revenue of $680 million versus roughly $661 million on the street, net income of $47 million against a net loss a year prior, and a return to positive EPS from continuing operations. They then raised full-year guidance, bumping adjusted FFO to $1.90–$2.00, and pointed to a "solid Q3 start." Comparable RevPAR was up 7%, hotel adjusted EBITDA up 9%, group rooms revenue up 9.5%. The stock popped toward $14.76.

Turnarounds that show up on an income statement are cheap to write about. The ones that survive tend to show up somewhere else. Notably, they did not show up here.

Adjusted FFO fell roughly 22% year-over-year to $79 million. That's the number. Not the revenue line, not the EBITDA line, the FFO line—the metric a hotel REIT actually gets judged on. Revenue can climb on pricing power while the cash in the register quietly drains out the bottom. And it's not a one-off wobble: forward EPS has been trimmed from $1.97 down to $1.79 over recent months, and next-quarter estimates are sitting at a laughable $0.02. Someone is quietly updating the model to a darker room.

Here's where the picture gets interesting, and where I part ways with the bullish version.

The balance sheet is not fine. We're talking $4.1 billion in total debt against about $3.1 billion in equity, a current ratio of 0.28, and $1.4 billion of 2026 maturities being rolled into new financing at roughly $13 million of incremental interest expense. The liquidity cushion is real—over $1 billion under the revolver, $600 million under a delayed-draw term loan—but a 0.28 current ratio means the company is running on a knife-edge of short-term obligations relative to what's due. Renovation pipeline? Yes, a $1 billion one that management claims will lift EBITDA ~60%. Promising. Unproven, and every dollar of capex comes right out of that same thin cash flow.

So now consider the tape. The stock rallied from around $8.50 earlier this year to a 52-week high of $16.20, and it's sitting near $15.43, jammed against a $15–$16 resistance wall that has repelled it more than once. It trades below its 200-day average by about 22%—a lagging trend, not a launchpad. Relative strength is neutral at 55. Nobody is euphoric here; if anything, the crowd is just now arriving after a 45% year.

And the analysts? They cannot agree on what this company is worth, which is itself the signal. Fair-value estimates range from roughly $9 to $27. Morgan Stanley is at $11, Wells Fargo at $15, JPMorgan at $13. The Zacks consensus average target lands near $17.15, but the consensus rating is "Hold," not "Buy," and some houses have cut targets. This is a stock where a reasonable, well-compensed professional can look at the exact same Q2 report and land on opposite ends of a $9–$27 band. That kind of disagreement isn't noise. It's the market telling you it doesn't know what it's pricing.

My read: Park is a genuine operational turnaround that has not yet proven itself as a cash-flow or balance-sheet story. The income statement got a pass it didn't fully earn. The multiple is doing the heavy lifting, not the fundamentals, and the market's own forecast of directional accuracy on this name is barely beating a coin flip—so treat any model projection as a range, not a target.

I would not chase it into $15.5–$16 on low conviction. That's the area where the bulls get caught with their pants down again. If I wanted exposure, I'd accumulate on weakness toward the $14.5–$14.8 zone, with a hard stop below $13.5, because the model's band is hinting at a deeper pullback—down toward $11, maybe $10.6—before anything stabilizes. The ~9% trailing dividend yield is a nice floor to hold onto through the volatility, and the ex-dividend date is September 30th, but a yield this fat often exists because the market is hedging its bet on the payout itself, and FFO is heading the wrong way.

The thing I keep coming back to: an earnings beat is a moment. A balance sheet is a verdict. Park just handed us a very good moment and a very fragile verdict. The smart money in this stock isn't buying the headline. It's pricing the gap between the two.

Play it like the gap exists, and you'll be fine either way.